LIBTAYO (Lib-TIE-oh) is a prescription medicine used to treat adults with a type
of lung cancer called non–small cell lung cancer (NSCLC) that has not spread outside
your chest (locally advanced lung cancer) and you cannot have surgery or chemotherapy
with radiation, or your lung cancer has spread to other areas of your body (metastatic lung
cancer), and your tumor does not have an abnormal “EGFR,” “ALK,” or “ROS1” gene.
LIBTAYO may be used as your first treatment:
It is not known if LIBTAYO is safe and effective in children.